PL413558A1 - Modified molecule of fibroblast 1 growth factor, molecule of nucleic acid coding the modified molecule of fibroblast 1 growth factor, application of the modified molecule of fibroblast 1 growth factor and pharmaceutical composition containing this molecule - Google Patents

Modified molecule of fibroblast 1 growth factor, molecule of nucleic acid coding the modified molecule of fibroblast 1 growth factor, application of the modified molecule of fibroblast 1 growth factor and pharmaceutical composition containing this molecule

Info

Publication number
PL413558A1
PL413558A1 PL413558A PL41355815A PL413558A1 PL 413558 A1 PL413558 A1 PL 413558A1 PL 413558 A PL413558 A PL 413558A PL 41355815 A PL41355815 A PL 41355815A PL 413558 A1 PL413558 A1 PL 413558A1
Authority
PL
Poland
Prior art keywords
molecule
growth factor
fibroblast
modified
modified molecule
Prior art date
Application number
PL413558A
Other languages
Polish (pl)
Other versions
PL228868B1 (en
Inventor
Piotr Tabaczewski
Mirosław Tabaczewski
Original Assignee
Piotr Tabaczewski
Mirosław Tabaczewski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piotr Tabaczewski, Mirosław Tabaczewski filed Critical Piotr Tabaczewski
Priority to PL413558A priority Critical patent/PL228868B1/en
Publication of PL413558A1 publication Critical patent/PL413558A1/en
Publication of PL228868B1 publication Critical patent/PL228868B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cytokina czynnik wzrostu fibroblastów-1 (FGF-1), należy do dużej grupy białek liczącej 23 warianty o podobnej strukturze, pełniących pokrywające się, lecz nie identyczne funkcje. Pobudzają one podziały mitotyczne wielu typów komórek, spośród których najważniejsze to fibroblasty, komórki śródbłonka naczyń i keratynocyty. Przedmiotem zgłoszenia jest sztucznie skonstruowana cząsteczka FGF-1 trzeciej generacji o ulepszonych właściwościach biologicznych i strukturalnych oraz o dodatkowych właściwościach pozwalających na osiągnięcie przewagi technologicznej.The cytokine fibroblast growth factor-1 (FGF-1) belongs to a large group of proteins with 23 variants of a similar structure, which perform overlapping but not identical functions. They stimulate mitotic division of many types of cells, among which the most important are fibroblasts, vascular endothelial cells and keratinocytes. The subject of the application is an artificially constructed third generation FGF-1 molecule with improved biological and structural properties as well as additional properties enabling technological advantage.

PL413558A 2015-08-13 2015-08-13 Modified molecule of fibroblast 1 growth factor, molecule of nucleic acid coding the modified molecule of fibroblast 1 growth factor, application of the modified molecule of fibroblast 1 growth factor and pharmaceutical composition containing this molecule PL228868B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL413558A PL228868B1 (en) 2015-08-13 2015-08-13 Modified molecule of fibroblast 1 growth factor, molecule of nucleic acid coding the modified molecule of fibroblast 1 growth factor, application of the modified molecule of fibroblast 1 growth factor and pharmaceutical composition containing this molecule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL413558A PL228868B1 (en) 2015-08-13 2015-08-13 Modified molecule of fibroblast 1 growth factor, molecule of nucleic acid coding the modified molecule of fibroblast 1 growth factor, application of the modified molecule of fibroblast 1 growth factor and pharmaceutical composition containing this molecule

Publications (2)

Publication Number Publication Date
PL413558A1 true PL413558A1 (en) 2017-02-27
PL228868B1 PL228868B1 (en) 2018-05-30

Family

ID=58091997

Family Applications (1)

Application Number Title Priority Date Filing Date
PL413558A PL228868B1 (en) 2015-08-13 2015-08-13 Modified molecule of fibroblast 1 growth factor, molecule of nucleic acid coding the modified molecule of fibroblast 1 growth factor, application of the modified molecule of fibroblast 1 growth factor and pharmaceutical composition containing this molecule

Country Status (1)

Country Link
PL (1) PL228868B1 (en)

Also Published As

Publication number Publication date
PL228868B1 (en) 2018-05-30

Similar Documents

Publication Publication Date Title
ES2657060T3 (en) Fusokines involving cytokines with strongly reduced receptor binding affinities
PE20110358A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF BONE DEFECTS WITH PLACENTARY CELL POPULATIONS
PE20250757A1 (en) INTERLEUKIN 21 MUTEINS AND TREATMENT METHODS
BR112014018630A2 (en) bleaching of chondroitin sulfate glycans
BR112020026125A8 (en) SUPERIOR OLIGONUCLEOTIDE OR 5'-CAP-TRINUCLEOTIDE COMPOUNDS AND THEIR USES IN RNA STABILIZATION, PROTEIN EXPRESSION AND IN THERAPY
CO2017009954A2 (en) Domains designed with ankyrine repeats with binding specificity for serum albumin
CO2019004006A2 (en) Method to increase the secretion levels of interleukin 2 and its derived proteins
UY38701A (en) MOLECULES OF BINDING TO CD19, CONJUGATES, COMPOSITIONS THAT INCLUDE THEM AND USES OF THE SAME
CL2008001674A1 (en) Simple variable domain (dab) of vascular endotlial growth anti-fator immunoglobulin (vegf); nucleoic acid that encodes it; vector and host cell; Method of production; antagonist of vegf comprising the dab; composition comprising the antagonist; and use of the antagonist to prepare a medication.
BR112017027498A2 (en) antibody, nucleic acid, compound, composition, and method for treating a patient with a disease.
MX395421B (en) ARTIFICIAL NUCLEIC ACID MOLECULES.
PE20140867A1 (en) AXMI-115, AXMI-113, AXMI-005, AXMI-163 AND AXMI-184: INSECTICIDE PROTEINS AND METHODS FOR THEIR USE
BR112017007765A2 (en) adenosine deaminase-2 (ada2) compositions, variants thereof and methods of using it
BR112015031639A2 (en) target integration
BR112014004130A8 (en) Isolated polynucleotides and polypeptides and methods of using them to increase plant production and/or agricultural characteristics
BR112015017338A8 (en) isolated antibody or protein, its pharmaceutical composition, its use, its production process, isolated nucleic acid molecule, cloning or expression vector, and host cell
AR092076A1 (en) HOMODIMERIC PROTEINS
BR112015021993A2 (en) Antioxidant cell culture compositions and methods for producing polypeptide
BR112015022210A8 (en) antibody formulations
CL2022001655A1 (en) Engineered variants of acid alpha-glucosidase.
BRPI0821034A8 (en) RECOMBINANT INFLUENZA B VIRUS, ITS USE, METHOD OF PREPARATION, COMPOSITION OF VACCINE CONTAINING O AND ITS M GENE, AS WELL AS ISOLATED NUCLEIC ACID, INFLUENZA M VIRUS MOLECULE AND ITS USE AND METHOD TO INCREASE THE GROWTH RATE OF REPLICATION DEFECTIVE INFLUENZA B VIRUSES
BRPI0813913A8 (en) NUCLEIC ACID MOLECULE, RECOMBINANT NUCLEIC ACID SEQUENCE, HOST CELL, METHODS FOR PRODUCING RECOMBINANT HUMAN FSH, AND FOR PRODUCING THE HOST CELL, AND, USE OF A NUCLEIC ACID SEQUENCE.
JP2016027797A5 (en)
CO2021005083A2 (en) Miniaturized dystrophins and their uses
MX382488B (en) STABLE NEURAL STEM CELLS COMPRISING AN EXOGENOUS POLYNUCLEOTIDE ENCODING A GROWTH FACTOR AND METHODS OF USING SAME.